Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma
Open Access
- 1 February 2024
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Journal of Zhejiang University (Medical Sciences)
- Vol. 53 (1) , 64-72
Abstract
Hepatocellular carcinoma (HCC) is a serious neoplastic disease with increasing incidence and mortality, accounting for 90% of all liver cancers. Hepatitis viruses are the major causative agents in the development of HCC. Hepatitis A virus (HAV) primarily causes acute infections, which is associated with HCC to a certain extent, as shown by clinicopathological studies. Chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections lead to persistent liver inflammation and cirrhosis, disrupt multiple pathways associated with cellular apoptosis and proliferation, and are the most common viral precursors of HCC. In particular, mutations in the HBV HBx gene are closely associated with the incidence of HCC, while the expression of HCV core proteins contributes to hepatocellular lipid accumulation, thereby promoting tumourigenesis. In the clinical setting, hepatitis D virus (HDV) frequently co-infects with HBV, increasing the risk of chronic hepatitis. Hepatitis E virus (HEV) usually causes acute infections, however, chronic infections of HEV are increasing recently, particularly in immuno-compromised patients and organ transplant recipients, which may increase the risk of progression to cirrhosis and the occurrence of HCC. Early detection, effective intervention and vaccination against these viruses may significantly reduce the incidence of liver cancer, while mechanistic insights into the interplay between hepatitis viruses and HCC may facilitate the development of more effective intervention strategies. This article provides a comprehensive overview of hepatitis viruses and reviews recent advances in research on aberrant hepatic immune responses and the pathogenesis of HCC due to viral infection.Keywords
This publication has 72 references indexed in Scilit:
- Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinomaNature Reviews Cancer, 2013
- Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune responseExpert Opinion on Biological Therapy, 2010
- Alcohol and Hepatitis C Virus–Interactions in Immune Dysfunctions and Liver DamageAlcohol, Clinical and Experimental Research, 2010
- Autoimmune hepatitis triggered by hepatitis AGut, 2007
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005
- Hepatocellular carcinoma associated with autoimmune hepatitisJournal of Hepato-Biliary-Pancreatic Surgery, 2004
- Human Hepatitis B Virus X Protein Is a Possible Mediator of Hypoxia-Induced Angiogenesis in HepatocarcinogenesisBiochemical and Biophysical Research Communications, 2000
- Hepatitis C: The clinical spectrum of diseaseHepatology, 1997
- Absence of an Association Between Past Infection with Hepatitis A Virus and Primary Hepatocellular CarcinomaInternational Journal of Epidemiology, 1980